IP Library › Granted Patent US 9,492,549
Granted Patent B2
US 9,492,549 · App. 13/640,652 · Granted Nov 15, 2016

Antimicrobial gels

Inventors: Peter Löwenhielm (Täby, SE); Malin Holmén (Göteborg, SE); Dennis Hansson (Gunnilse, SE); Sofia Bergstrand (Kungsbacka, SE); Stefan Areskoug (Göteborg, SE)
Assignee: Mölnlycke Health Care AB
A61K47/38A61K47/10A61L15/26A61L15/46A61L26/0019A61L26/0066A61L2300/104A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,492,549
App. No.
13/640,652
Granted
Nov 15, 2016
Kind
B2
Abstract

The present invention pertains to antimicrobial compositions comprising inter alia at least one alkenyl- and/or alkynyl-substituted polysiloxane, at least one polysiloxane comprising silicon-bonded hydrogen atoms, and at least one hydrosilylation catalyst, as well as antimicrobial silicone gels, wound dressings, and methods of preparing the above.

Claims (84)

1. An antimicrobial composition comprising at least one alkenyl- and/or alkynyl-substituted polysiloxane, at least one polysiloxane comprising silicon-bonded hydrogen atoms, and at least one hydrosilylation catalyst, wherein the composition further comprises at least one silver salt and at least one hydrophilic component, wherein the at least one hydrophilic component promotes release of the at least one silver salt such that the antimicrobial composition has an accumulated silver release of at least 0.3% of the total silver content in the initial antimicrobial composition after 24 hours, and wherein the at least one hydrophilic component makes the antimicrobial composition, when cross-linked, swell at least 5% (wt/wt) after 24 hours in a water solution containing 8.298 g/L of sodium chloride and 0.368 g/L of calcium chloride dihydrate, as measured by the free swell absorption method, wherein the at least one alkenyl- and/or alkynyl-substituted polysiloxane is covalently crosslinked to the at least one polysiloxane comprising silicon-bonded hydrogen atoms, thereby forming an antimicrobial gel.

2. The antimicrobial composition of claim 1 , wherein the at least one hydrophilic component comprises a glucose, xylitol, sorbitol, mannitol, cyclodextrin, cellulose, hemicellulose, carboxymethylated cellulose, chitosan, dextran, chitin, amylose, amylopectin, polyethylene glycol, polypropylene glycol, copolymer of polyethylene glycol and polypropylene glycol, polyglycerol, poly(acrylic acid), copolymer of acrylic acid and C 10 -C 30 alkyl acrylate, poly(acrylamide), maleic anhydride polymer, maleic anhydride copolymer, or carboxy methyl cellulose, methyl cellulose, hydroxymethylpropylcellulose, ethylcellulose, carboxyethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cellulose alkyl sulfonate, polystyrene sulphonate, vinyl acid, vinyl alcohol, or a mixture thereof.

3. The antimicrobial composition of claim 1 , wherein the concentration of the at least one hydrophilic component is between 3% and 40% (w/w).

4. The antimicrobial composition of claim 1 , wherein the antimicrobial composition further comprises between 1% and 5% (w/w) silica particles.

5. The antimicrobial composition of claim 1 , wherein the silver salt concentration is between 1% and 30% (w/w).

6. The antimicrobial composition of claim 1 , wherein the antimicrobial composition further comprises at least one siloxane-containing copolymer.

7. The antimicrobial composition of claim 6 , wherein the at least one siloxane-containing copolymer comprises at least one siloxane polymer network, at least one siloxane polyether (SPE), or a mixture thereof.

8. The antimicrobial composition of claim 6 , wherein the at least one siloxane-containing copolymer is present at a concentration of between 0.1% and 30% (w/w).

9. The antimicrobial composition of claim 7 , wherein the at least one siloxane-containing copolymer is the at least one siloxane polymer network, wherein the at least one siloxane polymer network comprises a poly-ether-siloxane copolymer network.

10. The antimicrobial composition according to claim 1 , wherein the at least one hydrophilic component comprises a mono-polysaccharide, di-polysaccharide, sugar alcohol, polyol, polyether, polyester, polyamide, polymer comprising a pendant carboxylic acid group, a polymer comprising a pendant sulphonate group, or a mixture thereof.

11. The antimicrobial composition of claim 1 , wherein the at least one silver salt comprises Ag 2 SO 4 , Ag 2 SO 3 ; AgNO 3 , Ag 2 CO 3 , Ag 3 PO 4 , silver zirconium, silver citrate, silver acetate, silver lactate, or a mixture thereof.

12. The antimicrobial composition of claim 1 , wherein the at least one hydrophilic component comprises a sorbitol, mannitol, polyethylene glycol, or carboxy methyl cellulose, or a mixture thereof.

13. An antimicrobial gel produced from a composition comprising at least one alkenyl- and/or alkynyl-substituted polysiloxane, at least one polysiloxane comprising silicon-bonded hydrogen atoms, and at least one hydrosilylation catalyst, wherein the composition further comprises at least one silver salt and at least one hydrophilic component, wherein the at least one hydrophilic component promotes release of the at least one silver salt such that the antimicrobial gel has an accumulated silver release of at least 0.3% of the total silver content in the initial antimicrobial gel after 24 hours, and wherein the at least one hydrophilic component makes the antimicrobial composition, when cross-linked, swell at least 5% (wt/wt) after 24 hours in a water solution containing 8.298 g/L of sodium chloride and 0.368 g/L of calcium chloride dihydrate, as measured by the free swell absorption method, wherein the gel is produced through crosslinking the at least one alkenyl- and/or alkynyl-substituted polysiloxane and the at least one polysiloxane comprising silicon-bonded hydrogen atoms.

14. The antimicrobial gel of claim 13 , wherein the crosslinking of the polysiloxanes is carried out using curing.

15. The antimicrobial gel of claim 13 , wherein the antimicrobial gel further comprises one or more excipients comprising a siloxane-containing copolymer, silica particle, or a mixture thereof.

16. The antimicrobial gel of claim 13 , wherein the corrected zone of inhibition (CZoI) of microbial growth brought about by the antimicrobial gel is at least 2 mm at 24 h.

17. The antimicrobial gel of claim 13 , wherein a circular sample of the antimicrobial gel, assessed using the two-compartment test method, having a diameter of about 20 mm and a coat weight of about 500 g/m 2 , when exposed to 4 ml of bacteria-containing chemical simulated wound fluid at a temperature of 37° C., is able to reduce the number of colony forming units (CFUs) of Staphylococcus aureus from 10 6 to at least 10 5 in 24 h.

18. The antimicrobial gel of claim 13 , wherein the gel has an adhesion with steel of between 0.1 and 2 N as measured by ASTM Internationals' standard D3330/D3330M-04, method F.

19. The antimicrobial gel of claim 13 , wherein the at least one hydrophilic component comprises a glucose, xylitol, sorbitol, mannitol, cyclodextrin, cellulose, hemicellulose, carboxymethylated cellulose, chitosan, dextran, chitin, amylose, amylopectin, polyethylene glycol, polypropylene glycol, copolymer of polyethylene glycol and polypropylene glycol, polyglycerol, poly(acrylic acid), copolymer of acrylic acid and C 10 -C 30 alkyl acrylate, poly(acrylamide), maleic anhydride polymer, maleic anhydride copolymer, or carboxy methyl cellulose, methyl cellulose, hydroxymethylpropylcellulose, ethylcellulose, carboxyethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cellulose alkyl sulfonate, polystyrene sulphonate, vinyl acid, vinyl alcohol, or a mixture thereof.

20. The antimicrobial gel of claim 13 , wherein the concentration of the at least one hydrophilic component is between 3% and 40% (w/w).

21. The antimicrobial gel of claim 13 , wherein the antimicrobial gel further comprises between 1% and 5% (w/w) silica particles.

22. The antimicrobial gel of claim 13 , wherein the silver salt concentration is between 1% and 30% (w/w).

23. The antimicrobial gel of claim 13 , wherein the antimicrobial gel further comprises at least one siloxane-containing copolymer.

24. The antimicrobial gel of claim 23 , wherein the at least one siloxane-containing copolymer comprises at least one siloxane polymer network, at least one SPE, or a mixture thereof.

25. The antimicrobial gel of claim 23 , wherein the at least one siloxane-containing copolymer is present at a concentration of between 0.1% and 30% (w/w).

26. The antimicrobial gel of claim 24 , wherein the at least one siloxane-containing copolymer is the at least one siloxane polymer network, wherein the at least one siloxane polymer network comprises a poly-ether-siloxane copolymer network.

27. The antimicrobial gel according to claim 13 , wherein the at least one hydrophilic component comprises a mono-polysaccharide, di-polysaccharide, sugar alcohol, polyol, polyether, polyester, polyamide, polymer comprising a pendant carboxylic acid group, a polymer comprising a pendant sulphonate group, or a mixture thereof.

28. The antimicrobial gel of claim 13 , wherein the at least one silver salt comprises Ag 2 SO 4 , Ag 2 SO 3 ; AgNO 3 , Ag 2 CO 3 , Ag 3 PO 4 , silver zirconium, silver citrate, silver acetate, silver lactate, or a mixture thereof.

29. The antimicrobial composition of claim 13 , wherein the at least one hydrophilic component comprises a sorbitol, mannitol, polyethylene glycol, or carboxy methyl cellulose, or a mixture thereof.

30. An antimicrobial dressing comprising the antimicrobial gel of claim 13 .

31. The antimicrobial dressing of claim 30 , wherein the antimicrobial gel is applied on a substrate.

32. The antimicrobial dressing of claim 30 , wherein the dressing comprises a wound dressing, an ostomy dressing, ostomy baseplate, incision film, surgical drape, a patch, a bandage, a band-aid, a plaster, an adhesive, an adhesive tape, an adhesive plaster, a sticking-plaster, a court-plaster, or a combination thereof.

33. A method for preparing an antimicrobial gel of claim 13 , comprising the following steps of:

(a) preparing the three mixtures (i), (ii), and (iii), either simultaneously or sequentially or in any combination of (i), (ii), and (iii), comprising;

(i) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one hydrosilylation catalyst and, optionally, silica particles;

(ii) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one chain extender and/or at least one crosslinker, and, optionally, silica particles;

(iii) at least one silver salt and at least one siloxane-containing copolymer;

(b) mixing at least one hydrophilic component with mixture (i) and/or mixture (ii), followed by optionally heating the mixture(s) to which the at least one hydrophilic component was added, in order to melt the at least one silver-release enhancing hydrophilic component;

(c) mixing mixture (iii) with mixture (i) and/or mixture (ii);

(d) mixing mixture (i) and mixture (ii); and

(e) curing the mixture obtained in step (d), thereby obtaining the antimicrobial gel.

34. A method for preparing an antimicrobial dressing of claim 30 , comprising the following steps of:

(a) preparing the three mixtures (i), (ii), and (iii), either simultaneously or sequentially or in any combination of (i), (ii), and (iii), comprising;

(i) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one hydrosilylation catalyst and, optionally, silica particles;

(ii) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one chain extender and/or at least one crosslinker, and, optionally, silica particles;

(iii) at least one silver salt and at least one siloxane-containing copolymer;

(b) mixing the at least one hydrophilic component with mixture (i) and/or mixture (ii), followed by optionally heating the mixture(s) to which the at least one hydrophilic component was added, in order to melt the hydrophilic component;

(c) mixing mixture (iii) with mixture (i) and/or mixture (ii) U;

(d) mixing mixture (i) and mixture (ii);

(e) coating a substrate with the mixture obtained in step (d); and

(f) curing the mixture coated on the substrate of step (e), thereby obtaining the antimicrobial dressing.

35. The method of claim 34 , wherein the substrate comprises a wound dressing, an ostomy dressing, an ostomy baseplate, an incision film, a surgical drape, a pad, a patch, a bandage, a band-aid, a plaster, an adhesive, an adhesive tape, an adhesive plaster, a sticking-plaster, a court-plaster, or a mixture thereof, or wherein the substrate is a component for production of any one of the above substrates, wherein the component for production comprises a film, a textile, a foam, a non-woven film, a fiber network, a knitted fabric, or a combination thereof.

36. A method for treating a burn, scar, bacterial infection, viral infection, and/or fungal infection, wherein the method comprises applying the antimicrobial gel of claim 13 to a patient in need thereof.

37. A method for treating a burn, scar, bacterial infection, viral infection, and/or fungal infection, wherein the method comprises applying the antimicrobial dressing of claim 30 to a patient in need thereof.

38. An antimicrobial gel comprising at least two polysiloxanes, wherein the antimicrobial gel is formed by creating at least one covalent bond between at least one an alkenyl and/or alkynyl moiety of a first polysiloxane and at least one Si—H moiety of a second polysiloxane, the antimicrobial gel further comprises at least one hydrosilylation catalyst, at least one silver salt, and at least one hydrophilic component, wherein the at least one hydrophilic component promotes release of the at least one silver salt such that the antimicrobial gel has an accumulated silver release of at least 0.3% of the total silver content in the initial antimicrobial gel after 24 hours, wherein the at least one hydrophilic component makes the antimicrobial gel swell at least 5% (wt/wt) after 24 hours in a water solution containing 8.298 g/L of sodium chloride and 0.368 g/L of calcium chloride dihydrate, as measured by the free swell absorption method.

39. The antimicrobial gel according to claim 38 , wherein the at least one hydrophilic component comprises a mono-polysaccharide, di-polysaccharide, sugar alcohol, polyol, polyether, polyester, polyamide, polymer comprising a pendant carboxylic acid group, a polymer comprising a pendant sulphonate group, or a mixture thereof.

40. The antimicrobial gel of claim 38 , wherein the at least one silver salt comprises Ag 2 SO 4 , Ag 2 SO 3 ; AgNO 3 , Ag 2 CO 3 , Ag 3 PO 4 , silver zirconium, silver citrate, silver acetate, silver lactate, or a mixture thereof.

41. The antimicrobial gel of claim 38 , wherein the antimicrobial gel further comprises one or more excipients comprising a siloxane-containing copolymer, silica particle, or a mixture thereof.

42. The antimicrobial gel of claim 38 , wherein the corrected zone of inhibition (CZoI) of microbial growth brought about by the antimicrobial gel is at least 2 mm at 24 h.

43. An antimicrobial dressing comprising the antimicrobial gel of claim 38 .

44. The antimicrobial dressing of claim 43 , wherein the antimicrobial gel is applied on a substrate.

45. The antimicrobial dressing of claim 43 , wherein the dressing comprises a wound dressing, an ostomy dressing, ostomy baseplate, incision film, surgical drape, a patch, a bandage, a band-aid, a plaster, an adhesive, an adhesive tape, an adhesive plaster, a sticking-plaster, a court-plaster, or a combination thereof.

46. A method for preparing an antimicrobial gel of claim 38 , comprising the following steps of:

(a) preparing the three mixtures (i), (ii), and (iii), either simultaneously or sequentially or in any combination of (i), (ii), and (iii), comprising;

(i) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one hydrosilylation catalyst and, optionally, silica particles;

(ii) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one chain extender and/or at least one crosslinker, and, optionally, silica particles;

(iii) at least one silver salt and at least one siloxane-containing copolymer;

(b) mixing at least one hydrophilic component with mixture (i) and/or mixture (ii), followed by optionally heating the mixture(s) to which the at least one hydrophilic component was added, in order to melt the at least one silver-release enhancing hydrophilic component;

(c) mixing mixture (iii) with mixture (i) and/or mixture (ii);

(d) mixing mixture (i) and mixture (ii); and

(e) curing the mixture obtained in step (d), thereby obtaining the antimicrobial gel.

47. A method for preparing an antimicrobial dressing of claim 43 , comprising the following steps of:

(a) preparing the three mixtures (i), (ii), and (iii), either simultaneously or sequentially or in any combination of (i), (ii), and (iii), comprising;

(i) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one hydrosilylation catalyst and, optionally, silica particles;

(ii) at least one alkenyl- and/or alkynyl-functional polysiloxane, at least one chain extender and/or at least one crosslinker, and, optionally, silica particles;

(iii) at least one silver salt and at least one siloxane-containing copolymer;

(b) mixing the at least one hydrophilic component with mixture (i) and/or mixture (ii), followed by optionally heating the mixture(s) to which the at least one hydrophilic component was added, in order to melt the hydrophilic component;

(c) mixing mixture (iii) with mixture (i) and/or mixture (ii) U;

(d) mixing mixture (i) and mixture (ii);

(e) coating a substrate with the mixture obtained in step (d); and

(f) curing the mixture coated on the substrate of step (e), thereby obtaining the antimicrobial dressing.

48. The method of claim 47 , wherein the substrate comprises a wound dressing, an ostomy dressing, an ostomy baseplate, an incision film, a surgical drape, a pad, a patch, a bandage, a band-aid, a plaster, an adhesive, an adhesive tape, an adhesive plaster, a sticking-plaster, a court-plaster, or a mixture thereof, or wherein the substrate is a component for production of any one of the above substrates, wherein the component for production comprises a film, a textile, a foam, a non-woven film, a fiber network, a knitted fabric, or a combination thereof.

49. A method for treating a burn, scar, bacterial infection, viral infection, and/or fungal infection, wherein the method comprises applying the antimicrobial gel of claim 38 to a patient in need thereof.

50. A method for treating a burn, scar, bacterial infection, viral infection, and/or fungal infection, wherein the method comprises applying the antimicrobial gel according of claim 38 to a patient in need thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2012
From: LOWENHIELM, PETER; HOLMEN, MALIN; HANSSON, DENNIS; BERGSTRAND, SOFIA; ARESKOUG, STEFAN
To: MOLNLYCKE HEALTH CARE AB
Reel/Frame 029269/0457 →
Priority Claims (1)
SE 1050367 · Apr 14, 2010 · national
Continuity (2)
Provisional Application 61323926 · Apr 14, 2010
Related Publication 20130101633A1 · Apr 25, 2013